SPECTRUM OF BRCA1, BRCA2, PALB2, ATM AND TP53 PATHOGENIC VARIANTS IN BREAST AND OVARIAN CANCER PATIENTS OF TATAR AND BASHKIR ETHNIC ORIGIN

被引：0
|
作者：
Imyanitov, Evgeny [1 ]
Bakayeva, Elvina [1 ]
Sultanbayev, Alexandr [2 ]
Faiskhanova, Raniya [2 ]
Mukhamediarova, Gulnara [3 ]
Fatikhova, Alfiya [2 ]
Askarov, Vadim [2 ]
Venina, Aigul [1 ]
Romanko, Alexandr [1 ]
Sokolenko, Anna [1 ]
机构：
[1] NN Petrov Inst Oncol, St Petersburg, Russia
[2] Bashkortostan Republican Canc Ctr, Ufa, Russia
[3] Tatarstan Republican Canc Ctr, Kazan, Russia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
10.1136/ijgc-2023-ESGO.779
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
432
引用
收藏
页码：A368 / A368
页数：1
相关论文
共 50 条
  • [21] Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina
    Cerretini, Roxana
    Mercado, Graciela
    Morganstein, Josh
    Schiaffi, Jorge
    Reynoso, Monica
    Montoya, Diana
    Valdez, Rita
    Narod, Steven A.
    Akbari, Mohammad R.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (03) : 629 - 636
  • [22] Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families
    Pylkas, Katri
    Erkko, Hannele
    Nikkila, Jenni
    Solyom, Szilvia
    Winqvist, Robert
    BMC CANCER, 2008, 8 (1)
  • [23] Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina
    Roxana Cerretini
    Graciela Mercado
    Josh Morganstein
    Jorge Schiaffi
    Mónica Reynoso
    Diana Montoya
    Rita Valdéz
    Steven A. Narod
    Mohammad R. Akbari
    Breast Cancer Research and Treatment, 2019, 178 : 629 - 636
  • [24] Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families
    Katri Pylkäs
    Hannele Erkko
    Jenni Nikkilä
    Szilvia Sólyom
    Robert Winqvist
    BMC Cancer, 8
  • [25] BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer
    Shehaj, Ina
    Krajnak, Slavomir
    Almstedt, Katrin
    Degirmenci, Yaman
    Herzog, Sophia
    Lebrecht, Antje
    Linz, Valerie Catherine
    Schwab, Roxana
    Stewen, Kathrin
    Brenner, Walburgis
    Hasenburg, Annette
    Schmidt, Marcus
    Heimes, Anne-Sophie
    BIOMEDICINES, 2024, 12 (06)
  • [26] Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
    Caroline Baynes
    Catherine S Healey
    Karen A Pooley
    Serena Scollen
    Robert N Luben
    Deborah J Thompson
    Paul DP Pharoah
    Douglas F Easton
    Bruce AJ Ponder
    Alison M Dunning
    Breast Cancer Research, 9
  • [27] Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
    Baynes, Caroline
    Healey, Catherine S.
    Pooley, Karen A.
    Scollen, Serena
    Luben, Robert N.
    Thompson, Deborah J.
    Pharoah, Paul D. P.
    Easton, Douglas F.
    Ponder, Bruce A. J.
    Dunning, Alison M.
    BREAST CANCER RESEARCH, 2007, 9 (02)
  • [28] Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
    Christos Petridis
    Iteeka Arora
    Vandna Shah
    Anargyros Megalios
    Charlotte Moss
    Anca Mera
    Angela Clifford
    Cheryl Gillett
    Sarah E. Pinder
    Ian Tomlinson
    Rebecca Roylance
    Michael A. Simpson
    Elinor J. Sawyer
    Breast Cancer Research, 21
  • [29] Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours
    Ramus, SJ
    Bobrow, LG
    Pharoah, PDP
    Finnigan, DS
    Fishman, A
    Altaras, M
    Harrington, PA
    Gayther, SA
    Ponder, BAJ
    Friedman, LS
    GENES CHROMOSOMES & CANCER, 1999, 25 (02): : 91 - 96
  • [30] The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib
    Brown, Timothy J.
    Yablonovitch, Arielle
    Till, Jacob E.
    Yen, Jennifer
    Kiedrowski, Lesli A.
    Hood, Ryan
    O'Hara, Mark H.
    Teitelbaum, Ursina
    Karasic, Thomas B.
    Schneider, Charles
    Carpenter, Erica L.
    Nathanson, Katherine
    Domchek, Susan M.
    Reiss, Kim A.
    CLINICAL CANCER RESEARCH, 2023, 29 (24) : 5207 - 5216
12345